 | • レポートコード：QYR2104Z1321 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、慢性リンパ性白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、生物学的療法、その他）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・慢性リンパ性白血病治療の市場動向 ・企業の競争状況、市場シェア ・慢性リンパ性白血病治療の種類別市場規模（化学療法、生物学的療法、その他） ・慢性リンパ性白血病治療の用途別市場規模（病院、クリニック、研究機関） ・慢性リンパ性白血病治療の北米市場規模2016-2027（アメリカ、カナダ） ・慢性リンパ性白血病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性リンパ性白血病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性リンパ性白血病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性リンパ性白血病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（4SC、AbbVie、ACEA Biosciences、ADC Therapeutics、Aeglea BioTherapeutics、Altor BioScience、Amgen、Aptevo Therapeutics、ArQule、Asana BioSciences、Astellas Pharma、Astex Pharmaceuticals、AstraZeneca、Baliopharm、Bayer、BeiGene、Bellicum Pharmaceuticals、Biogen、Bionomics、Biothera Pharmaceutical） ・結論 |
Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of monoclonal disorder and is commonly found in adults in western countries. Based on the severity, patients diagnosed with chronic lymphocytic leukemia die within 2 to 10 years.
Geographically, global relapse Chronic Lymphocytic Leukemia (CLL) treatment market is segmented into North America, Asia Pacific, Europe, and Rest of the World regions. Currently, North America is dominating the global relapse Chronic Lymphocytic Leukemia (CLL) treatment market and is closely followed by Europe. Highly developed healthcare infrastructure, higher healthcare spending, availability of reimbursement policies, higher rates of awareness about relapse Chronic Lymphocytic Leukemia (CLL) and related treatments, availability of highly advanced healthcare tools and higher rates of adoption of new techniques in practice are some of the factors that are driving the Chronic Lymphocytic Leukemia (CLL) treatment market in North America and Europe.
Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Treatment Market
The global Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ 17350 million by 2026, from US$ 8411.2 million in 2019, at a CAGR of 10.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Lymphocytic Leukemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Lymphocytic Leukemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Lymphocytic Leukemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Lymphocytic Leukemia Treatment market.
Global Chronic Lymphocytic Leukemia Treatment Scope and Market Size
Chronic Lymphocytic Leukemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Lymphocytic Leukemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Biological Therapy
Others
Segment by Application
Hospitals
Clinics
Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
4SC
AbbVie
ACEA Biosciences
ADC Therapeutics
Aeglea BioTherapeutics
Altor BioScience
Amgen
Aptevo Therapeutics
ArQule
ADC Therapeutics
Aeglea BioTherapeutics
Astex Pharmaceuticals
AstraZeneca
Baliopharm
Bayer
BeiGene
Bellicum Pharmaceuticals
Biogen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Biological Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chronic Lymphocytic Leukemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Lymphocytic Leukemia Treatment Market Perspective (2016-2027)
2.2 Chronic Lymphocytic Leukemia Treatment Growth Trends by Regions
2.2.1 Chronic Lymphocytic Leukemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Lymphocytic Leukemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Lymphocytic Leukemia Treatment Industry Dynamic
2.3.1 Chronic Lymphocytic Leukemia Treatment Market Trends
2.3.2 Chronic Lymphocytic Leukemia Treatment Market Drivers
2.3.3 Chronic Lymphocytic Leukemia Treatment Market Challenges
2.3.4 Chronic Lymphocytic Leukemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Lymphocytic Leukemia Treatment Players by Revenue
3.1.1 Global Top Chronic Lymphocytic Leukemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Lymphocytic Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Lymphocytic Leukemia Treatment Revenue
3.4 Global Chronic Lymphocytic Leukemia Treatment Market Concentration Ratio
3.4.1 Global Chronic Lymphocytic Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Lymphocytic Leukemia Treatment Revenue in 2020
3.5 Chronic Lymphocytic Leukemia Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Lymphocytic Leukemia Treatment Product Solution and Service
3.7 Date of Enter into Chronic Lymphocytic Leukemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Lymphocytic Leukemia Treatment Breakdown Data by Type
4.1 Global Chronic Lymphocytic Leukemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Type (2022-2027)
5 Chronic Lymphocytic Leukemia Treatment Breakdown Data by Application
5.1 Global Chronic Lymphocytic Leukemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
6.2 North America Chronic Lymphocytic Leukemia Treatment Market Size by Type
6.2.1 North America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Lymphocytic Leukemia Treatment Market Size by Application
6.3.1 North America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Lymphocytic Leukemia Treatment Market Size by Country
6.4.1 North America Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
7.2 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Type
7.2.1 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Application
7.3.1 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Country
7.4.1 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
9.2 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Type
9.2.1 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Application
9.3.1 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Country
9.4.1 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 4SC
11.1.1 4SC Company Details
11.1.2 4SC Business Overview
11.1.3 4SC Chronic Lymphocytic Leukemia Treatment Introduction
11.1.4 4SC Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.1.5 4SC Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Chronic Lymphocytic Leukemia Treatment Introduction
11.2.4 AbbVie Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 ACEA Biosciences
11.3.1 ACEA Biosciences Company Details
11.3.2 ACEA Biosciences Business Overview
11.3.3 ACEA Biosciences Chronic Lymphocytic Leukemia Treatment Introduction
11.3.4 ACEA Biosciences Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.3.5 ACEA Biosciences Recent Development
11.4 ADC Therapeutics
11.4.1 ADC Therapeutics Company Details
11.4.2 ADC Therapeutics Business Overview
11.4.3 ADC Therapeutics Chronic Lymphocytic Leukemia Treatment Introduction
11.4.4 ADC Therapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.4.5 ADC Therapeutics Recent Development
11.5 Aeglea BioTherapeutics
11.5.1 Aeglea BioTherapeutics Company Details
11.5.2 Aeglea BioTherapeutics Business Overview
11.5.3 Aeglea BioTherapeutics Chronic Lymphocytic Leukemia Treatment Introduction
11.5.4 Aeglea BioTherapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.5.5 Aeglea BioTherapeutics Recent Development
11.6 Altor BioScience
11.6.1 Altor BioScience Company Details
11.6.2 Altor BioScience Business Overview
11.6.3 Altor BioScience Chronic Lymphocytic Leukemia Treatment Introduction
11.6.4 Altor BioScience Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.6.5 Altor BioScience Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Chronic Lymphocytic Leukemia Treatment Introduction
11.7.4 Amgen Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Aptevo Therapeutics
11.8.1 Aptevo Therapeutics Company Details
11.8.2 Aptevo Therapeutics Business Overview
11.8.3 Aptevo Therapeutics Chronic Lymphocytic Leukemia Treatment Introduction
11.8.4 Aptevo Therapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.8.5 Aptevo Therapeutics Recent Development
11.9 ArQule
11.9.1 ArQule Company Details
11.9.2 ArQule Business Overview
11.9.3 ArQule Chronic Lymphocytic Leukemia Treatment Introduction
11.9.4 ArQule Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.9.5 ArQule Recent Development
11.10 Asana BioSciences
11.10.1 Asana BioSciences Company Details
11.10.2 Asana BioSciences Business Overview
11.10.3 Asana BioSciences Chronic Lymphocytic Leukemia Treatment Introduction
11.10.4 Asana BioSciences Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.10.5 Asana BioSciences Recent Development
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Details
11.11.2 Astellas Pharma Business Overview
11.11.3 Astellas Pharma Chronic Lymphocytic Leukemia Treatment Introduction
11.11.4 Astellas Pharma Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.11.5 Astellas Pharma Recent Development
11.12 Astex Pharmaceuticals
11.12.1 Astex Pharmaceuticals Company Details
11.12.2 Astex Pharmaceuticals Business Overview
11.12.3 Astex Pharmaceuticals Chronic Lymphocytic Leukemia Treatment Introduction
11.12.4 Astex Pharmaceuticals Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.12.5 Astex Pharmaceuticals Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Chronic Lymphocytic Leukemia Treatment Introduction
11.13.4 AstraZeneca Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.13.5 AstraZeneca Recent Development
11.14 Baliopharm
11.14.1 Baliopharm Company Details
11.14.2 Baliopharm Business Overview
11.14.3 Baliopharm Chronic Lymphocytic Leukemia Treatment Introduction
11.14.4 Baliopharm Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.14.5 Baliopharm Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Chronic Lymphocytic Leukemia Treatment Introduction
11.15.4 Bayer Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.15.5 Bayer Recent Development
11.16 BeiGene
11.16.1 BeiGene Company Details
11.16.2 BeiGene Business Overview
11.16.3 BeiGene Chronic Lymphocytic Leukemia Treatment Introduction
11.16.4 BeiGene Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.16.5 BeiGene Recent Development
11.17 Bellicum Pharmaceuticals
11.17.1 Bellicum Pharmaceuticals Company Details
11.17.2 Bellicum Pharmaceuticals Business Overview
11.17.3 Bellicum Pharmaceuticals Chronic Lymphocytic Leukemia Treatment Introduction
11.17.4 Bellicum Pharmaceuticals Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.17.5 Bellicum Pharmaceuticals Recent Development
11.18 Biogen
11.18.1 Biogen Company Details
11.18.2 Biogen Business Overview
11.18.3 Biogen Chronic Lymphocytic Leukemia Treatment Introduction
11.18.4 Biogen Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.18.5 Biogen Recent Development
11.18 Bionomics
.1 Bionomics Company Details
.2 Bionomics Business Overview
.3 Bionomics Chronic Lymphocytic Leukemia Treatment Introduction
.4 Bionomics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
.5 Bionomics Recent Development
11.20 Biothera Pharmaceutical
11.20.1 Biothera Pharmaceutical Company Details
11.20.2 Biothera Pharmaceutical Business Overview
11.20.3 Biothera Pharmaceutical Chronic Lymphocytic Leukemia Treatment Introduction
11.20.4 Biothera Pharmaceutical Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.20.5 Biothera Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Biological Therapy
Table 4. Key Players of Others
Table 5. Global Chronic Lymphocytic Leukemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Lymphocytic Leukemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Lymphocytic Leukemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2016-2021)
Table 9. Global Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2022-2027)
Table 11. Chronic Lymphocytic Leukemia Treatment Market Trends
Table 12. Chronic Lymphocytic Leukemia Treatment Market Drivers
Table 13. Chronic Lymphocytic Leukemia Treatment Market Challenges
Table 14. Chronic Lymphocytic Leukemia Treatment Market Restraints
Table 15. Global Chronic Lymphocytic Leukemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Chronic Lymphocytic Leukemia Treatment Market Share by Players (2016-2021)
Table 17. Global Top Chronic Lymphocytic Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lymphocytic Leukemia Treatment as of 2020)
Table 18. Ranking of Global Top Chronic Lymphocytic Leukemia Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Chronic Lymphocytic Leukemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Lymphocytic Leukemia Treatment Product Solution and Service
Table 22. Date of Enter into Chronic Lymphocytic Leukemia Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Chronic Lymphocytic Leukemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. 4SC Company Details
Table 63. 4SC Business Overview
Table 64. 4SC Chronic Lymphocytic Leukemia Treatment Product
Table 65. 4SC Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 66. 4SC Recent Development
Table 67. AbbVie Company Details
Table 68. AbbVie Business Overview
Table 69. AbbVie Chronic Lymphocytic Leukemia Treatment Product
Table 70. AbbVie Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 71. AbbVie Recent Development
Table 72. ACEA Biosciences Company Details
Table 73. ACEA Biosciences Business Overview
Table 74. ACEA Biosciences Chronic Lymphocytic Leukemia Treatment Product
Table 75. ACEA Biosciences Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 76. ACEA Biosciences Recent Development
Table 77. ADC Therapeutics Company Details
Table 78. ADC Therapeutics Business Overview
Table 79. ADC Therapeutics Chronic Lymphocytic Leukemia Treatment Product
Table 80. ADC Therapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 81. ADC Therapeutics Recent Development
Table 82. Aeglea BioTherapeutics Company Details
Table 83. Aeglea BioTherapeutics Business Overview
Table 84. Aeglea BioTherapeutics Chronic Lymphocytic Leukemia Treatment Product
Table 85. Aeglea BioTherapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 86. Aeglea BioTherapeutics Recent Development
Table 87. Altor BioScience Company Details
Table 88. Altor BioScience Business Overview
Table 89. Altor BioScience Chronic Lymphocytic Leukemia Treatment Product
Table 90. Altor BioScience Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 91. Altor BioScience Recent Development
Table 92. Amgen Company Details
Table 93. Amgen Business Overview
Table 94. Amgen Chronic Lymphocytic Leukemia Treatment Product
Table 95. Amgen Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 96. Amgen Recent Development
Table 97. Aptevo Therapeutics Company Details
Table 98. Aptevo Therapeutics Business Overview
Table 99. Aptevo Therapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 100. Aptevo Therapeutics Recent Development
Table 101. ArQule Company Details
Table 102. ArQule Business Overview
Table 103. ArQule Chronic Lymphocytic Leukemia Treatment Product
Table 104. ArQule Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 105. ArQule Recent Development
Table 106. Asana BioSciences Company Details
Table 107. Asana BioSciences Business Overview
Table 108. Asana BioSciences Chronic Lymphocytic Leukemia Treatment Product
Table 109. Asana BioSciences Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 110. Asana BioSciences Recent Development
Table 111. Astellas Pharma Company Details
Table 112. Astellas Pharma Business Overview
Table 113. Astellas Pharma Chronic Lymphocytic Leukemia Treatment Product
Table 114. Astellas Pharma Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 115. Astellas Pharma Recent Development
Table 116. Astex Pharmaceuticals Company Details
Table 117. Astex Pharmaceuticals Business Overview
Table 118. Astex Pharmaceuticals Chronic Lymphocytic Leukemia Treatment Product
Table 119. Astex Pharmaceuticals Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 120. Astex Pharmaceuticals Recent Development
Table 121. AstraZeneca Company Details
Table 122. AstraZeneca Business Overview
Table 123. AstraZeneca Chronic Lymphocytic Leukemia Treatment Product
Table 124. AstraZeneca Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 125. AstraZeneca Recent Development
Table 126. Baliopharm Company Details
Table 127. Baliopharm Business Overview
Table 128. Baliopharm Chronic Lymphocytic Leukemia Treatment Product
Table 129. Baliopharm Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 130. Baliopharm Recent Development
Table 131. Bayer Company Details
Table 132. Bayer Business Overview
Table 133. Bayer Chronic Lymphocytic Leukemia Treatment Product
Table 134. Bayer Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 135. Bayer Recent Development
Table 136. BeiGene Company Details
Table 137. BeiGene Business Overview
Table 138. BeiGene Chronic Lymphocytic Leukemia Treatment Product
Table 139. BeiGene Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 140. BeiGene Recent Development
Table 141. Bellicum Pharmaceuticals Company Details
Table 142. Bellicum Pharmaceuticals Business Overview
Table 143. Bellicum Pharmaceuticals Chronic Lymphocytic Leukemia Treatment Product
Table 144. Bellicum Pharmaceuticals Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 145. Bellicum Pharmaceuticals Recent Development
Table 146. Biogen Company Details
Table 147. Biogen Business Overview
Table 148. Biogen Chronic Lymphocytic Leukemia Treatment Product
Table 149. Biogen Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 150. Biogen Recent Development
Table 151. Bionomics Company Details
Table 152. Bionomics Business Overview
Table 153. Bionomics Chronic Lymphocytic Leukemia Treatment Product
Table 154. Bionomics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 155. Bionomics Recent Development
Table 156. Biothera Pharmaceutical Company Details
Table 157. Biothera Pharmaceutical Business Overview
Table 158. Biothera Pharmaceutical Chronic Lymphocytic Leukemia Treatment Product
Table 159. Biothera Pharmaceutical Revenue in Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 160. Biothera Pharmaceutical Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Lymphocytic Leukemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Biological Therapy Features
Figure 4. Others Features
Figure 5. Global Chronic Lymphocytic Leukemia Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Chronic Lymphocytic Leukemia Treatment Report Years Considered
Figure 10. Global Chronic Lymphocytic Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chronic Lymphocytic Leukemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Lymphocytic Leukemia Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2022-2027)
Figure 14. Global Chronic Lymphocytic Leukemia Treatment Market Share by Players in 2020
Figure 15. Global Top Chronic Lymphocytic Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lymphocytic Leukemia Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chronic Lymphocytic Leukemia Treatment Revenue in 2020
Figure 17. Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 21. North America Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 22. North America Chronic Lymphocytic Leukemia Treatment Market Share by Country (2016-2027)
Figure 23. United States Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 27. Europe Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 28. Europe Chronic Lymphocytic Leukemia Treatment Market Share by Country (2016-2027)
Figure 29. Germany Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chronic Lymphocytic Leukemia Treatment Market Share by Region (2016-2027)
Figure 39. China Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Chronic Lymphocytic Leukemia Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chronic Lymphocytic Leukemia Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. 4SC Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 59. AbbVie Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 60. ACEA Biosciences Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 61. ADC Therapeutics Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 62. Aeglea BioTherapeutics Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 63. Altor BioScience Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 65. Aptevo Therapeutics Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 66. ArQule Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 67. Asana BioSciences Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 68. Astellas Pharma Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 69. Astex Pharmaceuticals Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 70. AstraZeneca Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 71. Baliopharm Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 72. Bayer Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 73. BeiGene Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 74. Bellicum Pharmaceuticals Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 75. Biogen Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 76. Bionomics Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 77. Biothera Pharmaceutical Revenue Growth Rate in Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
世界の慢性リンパ性白血病治療市場規模・現状・予測（2021年-2027年） Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of monoclonal disorder and is commonly found in adults in western countries. Based on the severity, patients diagnosed with chronic lymphocytic leukemia die wi…- 世界の慢性リンパ性白血病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market size is projected to reach US$ 17350 million by 2026, from US$ 8411.2 million in 2019, at a CAGR of 10.8% during 2021-2026. With industry-standard accurac…
- 世界の慢性骨髄性白血病治療市場規模・現状・予測（2021年-2027年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…
- 世界の慢性骨髄性白血病治療市場規模・現状・予測（2021年-2027年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…
- 世界の急性リンパ性/リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年） Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. Market Analysis and Insights: Global Acute Lymphocytic/Lymphoblastic Leukemia Treatment Market The global Acute Lymphocytic/Lymphoblastic Leuk…